Filing Flows

Filing Flows › vTv Therapeutics (VTVT) › Next earnings date

vTv Therapeutics (VTVT) earnings: beat the estimate

vTv Therapeutics (VTVT) reported on Nov 5, 2026 and beat the EPS estimate: −$0.94 against −$1.06 (+11.7%). It beat the EPS estimate in 80% of the quarters on record.

Last result+11.7% vs estimate
Beat rate80%

The last report

vTv Therapeutics reported revenue of $36.8M for the first quarter 2026, net earnings $24.1M. How it makes money → · Every quarter →

vTv Therapeutics: EPS against the estimate, last 5 reportsvTv Therapeutics: EPS against the estimate, last 5 reportsEstimateReported−$0.98−$1.08Nov 25−$1.09−$0.58Mar 26$0.21$1.65May 26−$1.08−$1.05Aug 26−$1.06−$0.94Nov 26
Latest (Nov 26): Estimate −$1.06, Reported −$0.94.

vTv Therapeutics' latest quarter

vTv Therapeutics, Q1 2026: revenue $36.8M, operating margin 63.1%, net earnings $24.1M, operating cash flow $9.2M. The chart follows the revenue to costs, profit and cash.

Questions

Did vTv Therapeutics beat earnings?

vTv Therapeutics (VTVT) reported on Nov 5, 2026 and beat the EPS estimate: −$0.94 against −$1.06 (+11.7%).

When does VTVT report earnings?

The next date is not set yet.

Does vTv Therapeutics usually beat earnings?

It beat the consensus EPS estimate in 80% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.